These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 15374171)
21. Low plasma lipid levels and increased cholesterol synthesis after partial ileal bypass plus lovastatin in hypercholesterolemic rabbits. Tijerina O; Dombrovskis S; Esper E; Matts JP; Campos CT; Buchwald H Surgery; 1988 Oct; 104(4):796-805. PubMed ID: 3175875 [TBL] [Abstract][Full Text] [Related]
22. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins. Shear CL; Franklin FA; Stinnett S; Hurley DP; Bradford RH; Chremos AN; Nash DT; Langendorfer A Circulation; 1992 Apr; 85(4):1293-303. PubMed ID: 1555273 [TBL] [Abstract][Full Text] [Related]
23. Plasma lipids, erythrocyte membrane lipids and blood pressure of hypertensive women after ingestion of dietary oleic acid from two different sources. Ruíz-Gutiérrez V; Muriana FJ; Guerrero A; Cert AM; Villar J J Hypertens; 1996 Dec; 14(12):1483-90. PubMed ID: 8986934 [TBL] [Abstract][Full Text] [Related]
24. Plasmalogen phospholipids - facts and theses to their antioxidative qualities. Brosche T Arch Gerontol Geriatr; 1997; 25(1):73-81. PubMed ID: 15374102 [TBL] [Abstract][Full Text] [Related]
25. Comparison of the short-term efficacy and tolerability of lovastatin and pravastatin in the management of primary hypercholesterolemia. McPherson R; Bedard J; Connelly P; Curnew G; Davignon J; Echenberg D; Lavin P; Leiter L; Lenis J; McQueen M Clin Ther; 1992; 14(2):276-91. PubMed ID: 1611649 [TBL] [Abstract][Full Text] [Related]
26. Antioxidant effects of lovastatin and vitamin E on experimental atherosclerosis in rabbits. Singh RB; Singh NK; Rastogi SS; Wander GS; Aslam M; Onouchi Z; Kummerow FA; Nangia S Cardiovasc Drugs Ther; 1997 Sep; 11(4):575-80. PubMed ID: 9358962 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of lovastatin in hypercholesterolemia in patients with systemic hypertension. D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC Am J Cardiol; 1993 Jan; 71(1):82-7. PubMed ID: 8093585 [TBL] [Abstract][Full Text] [Related]
28. Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males. Cuchel M; Schaefer EJ; Millar JS; Jones PJ; Dolnikowski GG; Vergani C; Lichtenstein AH Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1910-7. PubMed ID: 9351353 [TBL] [Abstract][Full Text] [Related]
29. Small supplements of N-3 fatty acids change serum low density lipoprotein composition by decreasing phospholid and apolipoprotein B concentrations in young adult women. Sanchez-Muniz FJ; Bastida S; Viejo JM; Terpstra AH Eur J Nutr; 1999 Feb; 38(1):20-7. PubMed ID: 10338684 [TBL] [Abstract][Full Text] [Related]
30. Effect of polyunsaturated isocaloric fat diets on plasma lipids, apolipoproteins and fatty acids. Blaton V; De Buyzere M; Declercq B; Pracetyo A; Vanderkelen G; Delanghe J; Spincemaille J Atherosclerosis; 1984 Oct; 53(1):9-20. PubMed ID: 6497946 [TBL] [Abstract][Full Text] [Related]
31. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia. März W; Grützmacher P; Paul D; Siekmeier R; Schoeppe W; Gross W Int J Clin Pharmacol Ther; 1994 Feb; 32(2):92-7. PubMed ID: 8004365 [TBL] [Abstract][Full Text] [Related]
32. Comparison of LDL trap assay to other tests of antioxidant capacity; effect of vitamin E and lovastatin treatment. Malminiemi K; Palomäki A; Malminiemi O Free Radic Res; 2000 Nov; 33(5):581-93. PubMed ID: 11200090 [TBL] [Abstract][Full Text] [Related]
33. A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia. D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC Am J Cardiol; 1992 Jan; 69(1):28-34. PubMed ID: 1729864 [TBL] [Abstract][Full Text] [Related]
35. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of hypolipemic effects of lovastatin and gemfibrozil]. Gavelli MS; Vitaliano E; Rossi FG; Serra T; Santini G; Bernardi G Clin Ter; 1991 Jan; 136(1):31-8. PubMed ID: 1826871 [TBL] [Abstract][Full Text] [Related]
36. The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial. Alaupovic P; Mack WJ; Knight-Gibson C; Hodis HN Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):715-22. PubMed ID: 9108785 [TBL] [Abstract][Full Text] [Related]
37. Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation. Zambón D; Ros E; Rodriguez-Villar C; Laguna JC; Vázquez M; Sanllehy C; Casals E; Sol JM; Hernández G Metabolism; 1999 Jan; 48(1):47-54. PubMed ID: 9920144 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia. Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066 [TBL] [Abstract][Full Text] [Related]
39. Effects of flaxseed oil on serum lipids and atherosclerosis in hypercholesterolemic rabbits. Lee P; Prasad K J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):227-35. PubMed ID: 14506548 [TBL] [Abstract][Full Text] [Related]
40. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial. Jula A; Marniemi J; Huupponen R; Virtanen A; Rastas M; Rönnemaa T JAMA; 2002 Feb; 287(5):598-605. PubMed ID: 11829698 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]